Previous studies (1) demonstrated in vivo neutralization of insulin by guinea pig antisera but no neutralization by rabbit anfisera. These observations suggested that rabbit antibodies were directed to antigenic determinants on insulin which were different from the determinants to which guinea pig antibodies were directed. This possibility was tested by measuring the ability of antibodies in one antiserum to bind to an insoluble insulin complex saturated with antibodies from a different antiserum. Rabbit antisera tested in this manner contained antibodies which bound to insulin sites to which guinea pig antibodies could not bind. More rarely, certain guinea pigs produced antibodies which bound to insulin sites to which rabbit antibodies could not bind. Similar antibody differences were noted within each of these two species, i.e., rabbits produced antibodies which bound to insulin sites to which other rabbit antibodies could not bind, and occasional guinea pigs produced antibodies which bound to insulin sites which other guinea pig antibodies could not bind.
(From the Department of Pathology, School of Medicine, University of California, Los Angeles)
(Received for publication, March 22, 1963) Previous studies (1) demonstrated in vivo neutralization of insulin by guinea pig antisera but no neutralization by rabbit anfisera. These observations suggested that rabbit antibodies were directed to antigenic determinants on insulin which were different from the determinants to which guinea pig antibodies were directed. This possibility was tested by measuring the ability of antibodies in one antiserum to bind to an insoluble insulin complex saturated with antibodies from a different antiserum. Rabbit antisera tested in this manner contained antibodies which bound to insulin sites to which guinea pig antibodies could not bind. More rarely, certain guinea pigs produced antibodies which bound to insulin sites to which rabbit antibodies could not bind. Similar antibody differences were noted within each of these two species, i.e., rabbits produced antibodies which bound to insulin sites to which other rabbit antibodies could not bind, and occasional guinea pigs produced antibodies which bound to insulin sites which other guinea pig antibodies could not bind. Studies with P3Ulabeled antisera show that the antiserum differences noted are caused by insulin antibodies directed to different determinants and not because of differences in relative dissociation of antibodies from the same determinant on the insulin molecule.
These results demonstrate that more than one antibody molecule can simultaneously react with an insulin molecule. Implicit within these observations is the probability that insulin has a multiplicity of antigenic determinants. The determinants to which insulin antibodies are directed appear to be a characteristic of each animal immunized. It is postulated therefore that genetic factors direct production of antibodies toward specific antigenic determinants when insulin is the antigen. These studies were performed under United States Public Health Service grant A6001, and in part from a grant from Eli Lilly & Company, Indianapolis.
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Materials and Methods
Antigens
l~ulin.--Three preparations of insulin were used in these studies. Lilly insulin (Lot 719106) 1 was a preparation of zinc crystals of beef insulin with a potency of 27.0 units/rag. Some hyperglycemic factor was present in this preparation. Novo insulin (Lot HPA61) 2 was a preparation of zinc crystals of pork and beef insulin (80 per cent pork and 20 per cent beef) with a potency of 22.9 units/rag. Novo insulin (Lot 033557 was a commercial preparation of ten times recrystallized beef insulin with a biological potency of 22.0 uuits/mg.
Alum-precipitated insulin (API) was prepared by suspending 50 mg insulin in 10 mI buffered saline (0.01 ~¢ phosphate buffer pH 7.4) and then adding 0.5 ml of 1 per cent alum, A1NH~(SO4)~. 12H20.
Insulin in Freund's adjuvant was prepared by adding 1.5 ml (7.5 rag) API to 10 ml Frennd's complete adjuvant (Hyland Laboratories).
Antisera
Rabbit Antisera to Lilly and Novo Insulin.--Antisera to Lilly and Novo insulin were developed in adult, male and female, New Zealand white rabbits by injecting 0.2 ml insulin in Frennd's adjuvant into each toe pad. 3 to 4 weeks later 0.5 ml of intravenous API was given as a booster and followed by another 0.5 ml within 48 to 72 hours. A sample of blood (3 to 4 ml) for testing was taken within 7 to 19 days following the second booster.
When high levels of antibody were observed, 50 ml of blood was taken from the marginal ear vein. When antibody levels were low, the booster injections were repeated and another sample of blood was obtained and tested. Following all antigen inoculations, the rabbits received 30 ml of 50 per cent glucose subcutaneously to minimize hypoglycemic reactions. Infections were minimized by adding 125 mg terramycin to 100 ml of the glucose solution.
Blood samples were allowed to stand at room temperature (25°C) for two hours and then stored overnight at 4°C. The following morning the serum was separated by centrifugation at 3,000 g for 10 minutes. Insulin antibody level of the serum was then determined, divided into aliquots, and stored at --80°C until used.
Rabbit antisera were inactivated at 56°C for 30 minutes and adsorbed for 10 minutes at room temperature with 10 mg of formalin-treated lyophillzed sheep erythroeytes per ml.
Guinea Pig Anlisera to Lilly and Novo Insulin.--Antlsera to Lilly and Novo insulin were developed in adult male and female mongrel guinea pigs by injecting 0.2 ml insulin in Frennd's adjuvant into each paw pad. They were desensitized 3 to 4 weeks later by the successive subcutaneous injections of 1 #g, 10 gg, and 100 #g API at 45 minute intervals and a second 100 /~g API 1 hour later. The animals were constantly watched and 0.5 ml of 1:100,000 epinephrine was injected intraperitoneaUy when symptoms of anaphylaxis appeared. Following each series of inoculations, 4 ml of 50 per cent glucose was given intraperitoneally to minimize hypoglycemic reactions.
1 week following the desensitization procedure, an animal was selected at random and a 7 to 10 ml test sample of blood was taken by cardiac puncture. If an adequate antibody titer was observed, all the guinea pigs which had been immunized were anesthetized with intraperitoneal nembutal (0.5 ml of 60 mg/ml), and exsanguinated from the carotid artery within t We wish to thank Dr. Otto K. Behrens, Eli Lilly & Company, for the generous supply of crystalline beef insulin.
We wish to thank Mr. H. Juncher, Novo Industri A/S, Copenhagen, Denmark, for the generous supply of crystalline pork and beef insulin and the 10X crystalline beef insulin.
1 to 2 days after the test sample was obtained. Guinea pig antisera were treated in the same manner as the rabbit antisera except that they were not adsorbed with sheep erythrocytes.
Solutions
Veronal-Buffcred Saline (VBS).--The diluent used for titrating complement and insulin anfisera was VBS pH 7.4 (2) containing 5 X 10 -4 M MgC12 and 1.5 X 10 -3 ~a CaC12 per liter.
Insulin.--insnlin was dissolved in 0.01 ~ Na0H equal to one-half the desired volume. To this was added an equal volume of 0.22 z~ phosphate buffer pH 7.4. Insulin solutions were stored at 4°C and discarded 3 days after preparation.
Complem~nt.--Adsorbed complement (C'a) was used for the hemolytic titration of insulin antibodies. Pools of fresh guinea pig sera were adsorbed with 10 mg/ml of the $2 fraction of sheep erythrocyte stroma (3) at room temperature (23°C) for 10 minutes while gently agitated and then centrifuged at approximately 2,000 g at 3°C for 15 minutes.
An aliquot was tested for complement activity and the remainder divided into 2 ml aliquots quick frozen in a dry ice-acetone bath and stored at --80°C. C', preparations maintained their complement activity for at least 6 months when prepared in this manner.
Titration of Complement (C'~)
" " ' carried out at (4-7).--All tttrations of C, were 50 per cent hemolytic end points. A unit of complement is defined as the smallest amount of C', which will cause lysis of 50 per cent of sensitized cells (1 ml of 1.25 per cent suspension) in a final volume of 1.5 ml after 30 minutes at 37°C.
Sheep Erythrocytes.--Sheep erythrocytes were stored as sheep blood collected in an equal volume of Alsever's solution (8) . This suspension was stored at 4°C and used for a period of 14 days.
Preparation of Insulin-Sensitized Erythrocytes (Insulin-Cells).--Insufin-cells were prepared
by conjugating insulin to the surface of washed sheep erythrocytes with bis-diazobenzidine (BDB) as previously described (9) .
Titration of Insulin Antibody Activity.--Insulin antibodies were measured by a modification of the immune hemolysis technique previously described. The hemolysis of insuiin-celis by
antibodies m the presence of excess C, has been shown to be proporttonal to antibody concentration with this method (9) . Antisera, serially diluted with VBS to a final volume of 0.5 ml, were cooled in an ice bath and twenty 50 per cent hemolytic units of C', in 0.3 ml was then added. Finally the cells (0.2 ml of a 2.5 per cent suspension) were added and evenly suspended by gentle shaking. All samples in a given experiment were then incubated in a 37"C water bath for 30 minutes and the non-hemolyzed cells were then separated by centrifugation at 3°C at approximately 2000 g for 5 minutes. The supematant solutions were decanted and 2 ml of water was added to each sample. The degree of hemolysis was measured by the extinction of each sample at 580 m# with a Beckman model DB spectrophotometer. This method is valid and reliable when antisera are standardized and large pools of standardized C'~ are prepared. It is also necessary to test the reagents (C~', BDB, insulin, or cells) when any is changed. Sp~fic inhibition of immune hemolysis was performed in each experiment by adding a known amount of insulin (50 Izg) in 0.05 ml to samples of diluted antisera prior to the addition of C'. Specificity of the system is controlled in this manner since the inhibition of hemolysis with insulin in this system has been demonstrated to possess a high degree of specificity (10) .
Insulin Cellulose Stroma (ICS)
Aggregates.--An insoluble insulin aggregate prepared by conjugating insulin to a mixture of ceilnlose and sheep erythrocyte stroma with BDB has been previously described (3)• Three types of ICS aggregates were prepared; one with Lilly insulin and the other two with preparations of Novo insulin. These ICS aggregates were washed twice with distilled water, lyophilized, and stored at 3°C until they were used• The ability of insulin antibodies to bind to ICS was observed for at least 3 months after they had been prepared in this manner.
RESULTS
Experimental Approach.--These experiments were designed to test whether antibodies in different antisera were directed to different antigenic determinants on insulin. A system was devised which enabled the estimation of the degree to which antibodies in one antiserum react with an insoluble insulin complex (ICS) which had been saturated with antibodies from a different antiserum. Theoretically if only one portion of the insulin molecule acts as the immunological determinant, then no reaction between insulin antibodies (ABe) and an insulin-antibody complex prepared with a different antiserum (AB1) would be expected, Case 1, Fig. 1 .
If, however, antibodies are directed to more than one determinant group on insulin, then some antibodies would be expected to cross-react with the insulin-ABI complex, Case 2, Fig. 1 . In this case, a decrease in total insulin-antibody activity in the test antiserum (ABe) should be noted.
To test this hypothesis a system consisting of an insoluble insulin aggregate (ICS) saturated with antibodies from a single antiserum (AB1) was incubated with several different test antisera (AB2).
The validity of such an experiment requires that the ICS be saturated with antibodies from the saturating antiserum (AB1) prior to the addition of the test antiserum (AB,), Fig. 1 .
Saturation of I C S with Insulin Antibodies.--The saturation of ICS with :~ Much greater differences in antibody concentrations were observed in these same samples at higher dilutions. ABx was tested b y repeatedly incubating aliquots of AB1 with a given amount of ICS. I t was found necessary to incubate the ICS a minimum of three times with ABe. The antibody activity in all experiments was tested at 4 different dilutions of antisera b y the immune hemolysis technique. In all cases tested, the ICS (20 m g / m l of antiserum) appeared to be saturated with insulin antibodies following the second incubation with ABe, because no decrease in antibody was ever observed in the supernatant of aliquots following the third incubation, Table I . I n no case was there observed an increase in antibodies following the second and third incubation of ICS with AB1. It appeared reasonable to assume that the ICS was saturated with antibodies by three repeat incubations with AB1 and any further incubation of AB~ with ICS would not be necessary.
To determine whether insulin antibodies were non-specificaUy adsorbed to F~G. 2. Criteria for estimating binding of AB~ to ABI-ICS the cellulose stroma (CS) component of the ICS, 1 ml aliquots of guinea pig 5C antiserum and two rabbit (C5 and C20) antisera were each incubated with 20 mg CS and 20 mg ICS, Table II . Antibody activity in the aliquots of insulin antisera which had been incubated with CS remained unchanged. However, a marked decrease in insulin antibody activity was noted in the same aliquots of insulin antisera which had been incubated with ICS. See Table I I and third  column of Table I . Consequently, it was assumed that the ICS aggregate saturated with AB1 could be used as a reliable model to determine whether antibodies were present in test antisera (AB2) which could bind to portions of the insulin molecule to which the antibodies in the saturating antiserum could not bind, Fig. 1 . had been incubated with ABrICS aggregate. The hemolytic titration curves were a plot of the hemoglobin released against the log of the reciprocal of the dilution of the test antisera, Fig. 2 . All such curves of the non-incubated AB~ and the AB~ which had been incubated with the ABrICS were plotted on the same graph paper. The area under each of these curves was then estimated by cutting out the respective segment of graph paper and weighing them to the closest milligram with an analytical balance. The per cent binding of AB~ was calculated from the differences in weight of graph paper representing the area under the hemolytic titration curve of non-incubated AB2 and that of the incubated AB2, Fig. 2 . This method appears to be very accurate and very reproducible. It is our impression that the hemolytic titration curves obtained from 5 aliquots of the same antiserum simultaneously tested were so reproducible that the error due to the method of calculating relative concentration of antibody was greater than the actual observed values, Table IIi . It was also felt that the maximum possible differences in comparing these aliquots was considerably less than 5 per cent. Therefore, antibody binding to ABrICS was considered to have taken place in those situations where incubated AB2 demon-strated a decrease in insulin antibodies of 10 per cent or more, when simultaneously compared to non-incubated ABe.
Quantitation of Binding of Insulin Antibodies in Test Antisera (AB2) to A B r ICS.--The
Insulin Antibody Binding in Rabbit AB~ to Guinea Pig ABI-ICS.--Table IV summarizes the results observed in a group of experiments in which 5 different guinea pig (1B, 2B, 2C , 5B, and 5C) ABrICS aggregates were prepared and 6 different rabbit AB2 (C5, C20, C23, C28, C29, and C30) were tested.
Insulin antibodies capable of binding with portions of the insulin molecule to which guinea pig antibodies could not bind were demonstrated in 4 (C5, C20, C23, and C30) of the 6 rabbit antisera (AB2) tested.
These results demonstrate the difficulty in attempting to predict qualitatively or quantitatively which rabbit AB~ possesses antibodies capable of binding to specified guinea pig ABI-ICS. In this regard, antiserum from rabbit C5 contained antibodies which bound to all three guinea pig ABrICS against which it was tested. Whereas rabbit C28 produced insulin antibodies not capable of binding to any of three guinea pig ABI-ICS. Rabbit C20 on the other hand, produced insulin antibodies which did not bind to ABI-ICS prepared with guinea pig 1B antiserum, but 57.5 per cent of the insulin antibodies in rabbit C20 antiserum did bind to AB~-ICS prepared with guinea pig 2B antiserum.
Antibodies produced by rabbits which bind to sites on the insulin molecule to which guinea pig antibodies cannot bind appear to possess a marked in-dividual variability. Their demonstration apparently is dependent upon the individual guinea pig antiserum used to saturate the ABrICS and also upon the individual rabbit antiserum tested. A multiplicity of antigenic determinants on the insulin molecule is therefore implicit in explaining the observed results.
Binding of Guinea Pig AB2 to Rabbit A B r l C S . --T h e binding of AB2 from six different guinea pig (1B, 1D, 2C, 2D, 3C , and 6B) insulin antisera was tested against four rabbit (C5, C20, C28, and C33) ABrlCS aggregates, Table V .
Only two of six guinea pig AB~ contained antibodies capable of binding with only one ABI-ICS prepared with rabbit C33 antiserum. There was a suggestion of binding of guinea pig AB, (3C) to ABrlCS prepared with rabbit C20 antiserum.
The binding of guinea pig AB~ to rabbit ABI-ICS was noted less frequently than the binding of rabbit AB~ to guinea pig ABI-ICS, Table IV . This may be due to a greater similarity between the antibodies produced by guinea pigs than those produced by rabbits, possibly because guinea pigs produce antibodies to fewer insulin determinants than do rabbits.
Binding of Rabbit A B~ to A B r l C S Saturated with Rabbit Insulin A ntibodies.--
The insulin antibody differences observed when rabbit antisera (ABe) were tested against guinea pig ABrlCS aggregates, Table IV 93 per cent of the insulin antibodies in test rabbit C28 antiserum was capable of combining with portions of the insulin molecule to which antibodies in the saturating antiserum from rabbit C33 could not combine, Table VI . These results demonstrate an individual variation in the antibodies produced by rabbits when immunized with insulin. This variability is concerned with the antigenic determinant to which the antibodies are directed. It appears that rabbits produce measurable amounts of antibodies to several antigenic determinants on insulin.
Binding of Guinea Pig (AB2) to ABI-ICS Saturated with Guinea Pig Insulin
Antibodies.--The observed variation in antibodies noted among rabbit insulin antisera was also noted among guinea pig antisera but to a lesser degree, Table  VII . Twenty-one experiments were performed in which 14 different guinea pig (ABe) anfisera were tested against seven guinea pig ABI-ICS aggregates.
Definitive binding of guinea pig AB2 to guinea pig ABI-ICS was noted in only three or possibly four of the experiments, Table VII , as compared to the binding of rabbit AB~ to rabbit ABI-ICS which was observed in seven of twelve experiments, Table VI . These results emphasize the greater degree of similarity among In order to test these two possibilities, antisera were labeled (11, 12) with I TM, and AB~q31-ICS aggregates were prepared. The relationship between dissociation of AB~ -~31 from AB~qS~-ICS to binding of antibodies in AB2 was then tested and a typical example of the results obtained is presented in Table  VIII . Rabbit C20 antiserum and guinea pig 3E antiserum were labeled with 1 TM, and AB~q31-ICS aggregates were prepared with each of these antisera. Insulin antibody binding to the labeled AB~-I~I-ICS was tested with four antisera (AB2). Three of the four AB2 contained antibodies which bound to the AB~'131-ICS prepared with labeled C20 antisera. However, only minimal differences in dissociation of I ~ were discernible as measured by radioactivity of the incubated ABe (4.3 per cent to 5.3 per cent) and that remaining with theAB~-I~I-ICS (93.9 per cent to 96.0 per cent). Only one of the same four AB2 contained antibodies capable of binding to the guinea pig AB~-131-ICS aggregate. Again, the amount of dissociation of antibodies in AB1 varied slightly as measured by the radioactivity remaining on the aggregate and that observed in the supernatant. It appears that no relationship between dissociation of AB~ "181 from "B " -B I-~1 I n° ICS to binding of A 2 to the ~ 1 -~o was demonstrable with these methods.
Since insulin antibodies probably represent only a minimal portion of all the labeled material attached to the AB~q31-ICS, the possibility exists that dissociation of AB1 may be quite significant in terms of absolute amounts of insulin antibodies attached to the ICS. Therefore the dissociation of AB~ may possibly account in part for the individual differences noted in the binding of antibodies from various AB~ to ABI-ICS. If this were the case then repeated incubations d the same test antiserum with a number of aliquots of a single ABI-ICS aggregate should cause a progressive decrease in antibody activity with each successive incubation. On the other hand if only the antibodies (in AB2) that could react with exposed portions of insulin on the ABI-ICS aggregate were removed, then repeat incubations of AB~ would result in a limited decrease of antibody activity observable only after the first few incubations.
Therefore, two test antisera were repeatedly incubated with aliquots of an insoluble insulin aggregate which had been saturated with an insulin antiserum. In addition, one of the test antisera was repeatedly incubated with aliquots of an insoluble insulin complex which had not been saturated with antibodies, Table IX .
TABLE IX
Comparison of Binding of Insulin Antobodies between ICS and ABt-ICS Aggregates
An aliquot of test antiserum (AB2) from rabbit C28 was incubated repeatedly with six fresh aliquots of insoluble insulin (ICS). A second aliquot of the same test antiserum was incubated repeatedly with six fresh aliquots of insoluble insulin which had been saturated with antibodies from serum C33 (ABx). A decrease in insulin antibodies was noted following each successive incubation with ICS, row 1, Table IX. On the other hand, a decrease in antibodies was noted only after the first and second incubations with ABI-ICS. No significant decrease in insulin antibody activity was noted following the third, fourth, fifth, and sixth successive incubations of test antiserum with ABx-ICS, row 2, Table IX .
In addition, aliquots of rabbit C5 antiserum (AB2) were incubated repeatedly with three fresh aliquots of ICS which had been saturated with antibodies (AB1) from either rabbit C20 or guinea pig 5C. Again a decrease in antibody activity was noted only after the first and second incubations and no decrease was observed after the third incubation of test antiserum with ABI-ICS, rows 3 and 4, Table IX .
The results do not appear to be compatible with the hypothesis that the individual variations noted in test antisera (ABe) were due to dissocation of insulin antibodies from ABI-ICS during the period of incubation with the test antisera. If dissociation of antibody does occur it probably does not result in the individual variations noted in AB2.
It is probable, therefore, that antibodies in ABs which bind to ABI-ICS aggregates are attaching to a portion of the insulin molecule to which the antibodies in AB1 cannot bind. Since these variations in antibodies are peculiar to the individual antiserum and cannot be predicted, it is postulated that a genetic control directs antibody production only to certain antigenic determinants on the insulin molecule.
DISCUSSION
The binding of antibodies in AB2 to ABI-ICS was reproducible regardless of which of the three insulin preparations was used to make the ICS. Nor has it been possible to relate the antibody variations observed to any group of antisera obtained from animals immunized with one of these insulin preparations. Consequently it would be unlikely that the observed antibody variations were due to contaminants or to differences in structure between the pig and beef insulin. The immune hemolysis reaction employed in these studies has been demonstrated to possess a high degree of specificity for insulin (10) . It is therefore reasonable to assume that the reactions between AB2 and ABI-ICS involve the insulin molecule and antibodies directed against it.
Recently, Yagi, Maier, and Pressman (13) have demonstrated two distinct classes of antibodies in the serum of guinea pigs immunized with beef insulin. One class of antibodies migrates with gamma globulin, the other with B2 globulin, and both are similar in size (7S globulins). We repeated these experiments and could not obt~n immune hemolysis with the B2 insulin antibodies. Consequently binding experiments comparing these two classes of insulin antibodies were not possible. It is not known to what degree the antibodies of these two classes vary with respect to the determinants on insulin to which they can bind.
Direct evidence that at least two antibodies can react with an insulin molecule has been demonstrated in all situations where antibodies in AB, bound to ABI-ICS aggregates. By selecting the appropriate AB2 it is probable that r~ore than two antibodies will simultaneously combine with the insulin molecule.
The probability that more than one antibody molecule can react with an insulin molecule has been inferred by the demonstration of precipitate formation with the insulin-antibody system by several independent investigators (14-18). The possibility exists, however, that the observed precipitates with antibody and insulin resulted because of physical chemical reactions coincident with a single antibody insulin combination and not because of lattice formation. Such structural alterations in the insulin-antibody complex may account for the pattern of cells noted in the hemagglutination reaction at very high dilutions of antiserum.
Berson and Yallow (19, 20) have demonstrated by ultracentrifugafion that the antibody-insulin complex sediments at a rate similar to (within experimental error) gamma globulin. They concluded therefore that only one antibody molecule reacts with an insulin molecule. Their calculation of the equilibrium constants between antibody and insulin was based on this conclusion.
The direct evidence presented in this investigation and the numerous independent observations of precipitation between antibody and insulin suggest that more than one antibody can react with an insulin molecule simultaneously. It is probable therefore that the equilibrium constants between antibody and insulin proposed by Berson and Yallow may be subject to change.
The present investigation does not allow the estimation of the number of determinant groups which the insulin molecule possesses. The portion of the insulin molecule toward which antibodies are produced appears to be an individual characteristic which varies from animal to animal. It is probable that the determinants to which one animal produces antibodies overlap determinants to which others produce antibodies. In this sense, it is possible that the insulin molecule has an infinite number of determinants and it may be erroneous to consider insulin as possessing finite, distinct antigenic determinants. It is probably more accurate to consider the insulin sites toward which an animal directs the antibodies it produces.
Previous studies demonstrated guinea pig antisera to be capable of neutralizing insulin whereas rabbit antisera could not (1). There is much less antibody variation among guinea pigs, Tables V and VII, than among rabbits,  Tables IV and VI , possibly because guinea pigs produce antibodies to fewer determinants than do rabbits. It may be that guinea pigs produce relatively greater amounts of antibodies toward a portion of the insulin molecule which is critical for biological activity in the rat. Rabbits may produce relatively smaller amounts of such antibodies, and the method demonstrating them with intact anesthetized rat may not be sufficiently sensitive. Preliminary results indicate that it may be possible to select an occasional rabbit capable of producing antiserum which will neutralize insulin.
These individual characteristics of antibodies when insulin is the antigen may possibly be related to the manner in which the insulin molecule is transported in circulation and not involve antibody production. Evidence has been presented that circulating insulin is bound by a carrier protein (21, 22) . It is possible that the external surface of such an insulin carrier complex exposed to the antibody-competent cells is the same as "self" and therefore non-antigenic.
Only those portions of the insulin molecule to which carrier protein or proteins attach would be capable of stimulating the production of antibodies.
If this postulate is correct, then there may be different binding sites between insulin and carrier protein in different animals, and the antigenic determinants would also vary in different animals. Therefore, insulin may be neutralized by antibody only in those animals which have binding sites between carrier protein and insulin differing from the animal in which the antibodies are produced. Experiments designed to test these possibilities are currently being investigated with inbred strains of guinea pigs and rabbits.
It is not known whether the variations in antibodies observed when animals are immunized with insulin will also be observed with unrelated, non-biologically active proteins. It would be presumptive, therefore, to postulate that the antibody variations noted are general and will be manifest in the antibodies engendered by all antigens.
Sl.7~gtcr A R y 1. A method is presented for measuring the degree to which insulin antibodies in one antiserum react with an insoluble insulin complex saturated with antibodies from a different antiserum.
2. Many rabbits produce antibodies which bind to portions of the insulin molecule to which antibodies from guinea pigs or other rabbits cannot bind.
3. Occasional guinea pigs produce antibodies which bind to portions of the insulin molecule to which antibodies from rabbits or other guinea pigs cannot bind.
4. Studies with labeled antisera and repeated incubations of test antisera with antibody insulin complexes demonstrate the individual antibody variations to be due to antibodies directed to different determinants and not to dissociation of antibodies from the same determinant on the insulin molecule.
5. More than one antibody molecule can simultaneously bind to an insulin molecule.
6. Insulin has a multiplicity of antigenic determinants. 7. The relationship between antigenic determinants, insulin antibodies, and neutralization of insulin by antisera is discussed.
8. The determinants to which insulin antibodies are directed appear to be characteristic for the individual rabbit or guinea pig immunized. It is postulated therefore that genetic factors direct antibody production toward specific determinants when insulin is the antigen. BIBLIOGRAPHY 1. Arquilla, E. R., Alexander, J. D., Ptacek, E. D., and Loosli, E. S., Studies on insulin neutralization by anfisera from various species. I. Methodology and assay of insulin with intact anesthetized rats, Diabetes, 1962, 11,412.
